PYRAZOLDERIVATE ALS STING-AGONISTEN
European patent · EP4526298 · In force
Register entry
- Publication number
- EP4526298
- Application number
- EP23727300
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 16, 2023
- Published
- Mar 26, 2025
- Granted
- Oct 28, 2026
- Protection ends at the latest
- May 15, 2043
- Next annual fee due
- May 31, 2027
- IPC classes
- C07D 401/14 (2006.01)C07D 487/04 (2006.01)A61K 31/4155 (2006.01)A61P 35/00 (2006.01)
- Priority
- WO PCT/CN2022/093600 18.05.2022WO PCT/CN2022/124648 11.10.2022WO PCT/CN2023/080862 10.03.2023WO PCT/CN2023/087630 11.04.2023
- PCT application
- PCT/EP2023/063042 16.05.2023
- PCT publication
- WO2023/222644 23.11.2023
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 28, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 28.10.2026
Parties
Inventor
LIU, Haixia
Shanghai 201203, CN
LIU, Yafei
Shanghai 201203, CN
WANG, Jianping
Shanghai 201203, CN
WU, Yao
Shanghai 201203, CN
ZHANG, Zhiwei
Shanghai 201203, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.